To clarify the effect of CAPON on AD pathology, we used an adeno-associated virus (AAV)-mediated approach to introduce CAPON cDNA into the brain of AppNL-G-F and AppNL-G-F/MAPT (hTau) double-KI mice which we newly developed. Here, MAPT is linked to Alzheimer disease.